Common cycles are 8 to 12 weeks on, then 4 to 8 weeks off, but protocols differ by peptide and clinical response
At Perfect B, NAD+ is administered subcutaneously, not via IV infusion
Cellular energy utilisation models
In humans theres essentially no data on half-life, mechanism, or long-term side effects (source)
The GIP receptor activation component of tirzepatide may provide additional effects, as GIP receptors are expressed on immune cells and adipocytes, potentially modulating inflammatory responses in these tissues
Peptides can adhere to the plastic or stopper, altering the dose, and the risk of contamination increases significantly over time